Results
|
|
1.
|
|
|
|
2.
|
|
|
|
3.
|
|
|
|
4.
|
|
|
|
5.
|
|
|
|
6.
|
|
|
|
7.
|
|
|
|
8.
|
|
|
|
9.
|
|
|
|
10.
|
|
|
|
11.
|
|
|
|
12.
|
|
|
|
13.
|
|
|
|
14.
|
|
|
|
15.
|
|
|
|
16.
|
|
|
|
17.
|
|
|
|
18.
|
|
|
|
19.
|
|
|
|
20.
|
Granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein versus granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for non-Hodgkin's lymphoma: results of a randomized double-blind trial. [electronic resource] by
- Vose, J M
- Pandite, A N
- Beveridge, R A
- Geller, R B
- Schuster, M W
- Anderson, J E
- LeMaistre, C F
- Ahmed, T
- Granena, A
- Keating, A
- Fernandez Ranada, J M
- Stiff, P J
- Tabbara, I
- Longo, W
- Copelan, E A
- Nichols, C
- Smith, A
- Topolsky, D L
- Bierman, P J
- Lebsack, M E
- Lange, M
- Garrison, L
Producer: 19970710
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 15
Availability: No items available.
|